Product Reports Resources Pricing Login Book a demo

BlueWind Medical

Biotech & Life Sciences · Herzliya, Israel · Founded 2010

Evelops and markets an innovative wireless neuro-stimulation device for the treatment of peripheral neuropathic pain MoreLess

BlueWind Medical is a healthcare startup that offers a revolutionary treatment for Urge Urinary Incontinence (UUI), a condition characterized by urgent bladder leaks. The company's flagship product, Revi, is a miniature device implanted near the ankle. This device sends signals to the bladder via nerves, helping manage UUI symptoms.

The company primarily serves patients suffering from UUI, a widespread condition that can significantly impact quality of life. The market for such a solution is substantial, given the prevalence of UUI and the lack of effective long-term treatments.

BlueWind Medical operates on a business-to-consumer model, selling its product directly to patients through healthcare providers. The company generates revenue from the sale of the Revi device and potentially from follow-up services related to the device's adjustment and maintenance.

Revi has shown promising results in clinical studies, with 8 out of 10 participants experiencing a reduction in leaks after one year. The device is implanted in a single outpatient procedure under local anesthesia, making it a convenient and less invasive treatment option.

In summary, BlueWind Medical is a promising startup offering a novel, effective, and convenient solution for UUI, a condition that affects a significant portion of the population.

Keywords: BlueWind Medical, Urge Urinary Incontinence, Revi, bladder control, healthcare startup, outpatient procedure, patient satisfaction, clinical studies, convenient treatment, revenue generation.

Company overview

BlueWind Medical company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2010
Headquarters
Herzliya, Israel
Employees
93
Open positions
3
Dealroom signal
66.4
client focusb2btechnologyHardwaretechnologyDeep Techsub industryBioTechnologysub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorBiotechnologysectorNeurologysectorMental HealthsectorNeuromodulation and NeurostimulationsectorTech for Medical ProfessionalssectorTech for PatientssectorBiotech and Pharma

Valuation & funding

BlueWind Medical funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt May 2026 $24M Undisclosed
LATE VCOther financing May 2026 $24M $320M Undisclosed
SERIES BOther financing May 2022 $64M $256M ConvaTec
DEBTDebt Jan 2022 $0 Armentum Partners
Showing 4 recorded eventsUnlock the complete deal history →

Growth signals

BlueWind Medical website traffic

Latest recorded traffic for BlueWind Medical is 2.4K monthly website visits, down 17.2% over the last three months. BlueWind Medical's team declined 6.1% over the past year.

Latest monthly visits2.4K 3-month web change-17.2% 1-year team growth-6.1%
Monthly website visits102 observations · Oct 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

BlueWind Medical compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

BlueWind Medical's talent

Book a demo to see the people
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on BlueWind Medical's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage
ConvaTec
Series B+ 1 investor entered at this stage
Armentum Partners

Global footprint

Where BlueWind Medical has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States54.5%
🇮🇱 Israel40.9%
🇮🇪 Ireland4.5%
3 countries shown

In the news

Latest news about BlueWind Medical

Recent press, funding announcements, and product moves mentioning BlueWind Medical — open to read from the original sources.

See all news

Market sentiment

What the market is saying about BlueWind Medical

An AI-synthesized read of the highest-engagement posts about BlueWind Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BlueWind Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.